Progress of prophylactic cranial irradiation in treatment of non-small cell lung cancer / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 73-76, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-934631
ABSTRACT
The incidence of brain metastases in patients with non-small cell lung cancer (NSCLC) has increased as a result of improved local control rate and survival rate. Prophylactic cranial irradiation (PCI) has been proven to reduce the incidence of brain metastases and improve survival rate in patients with NSCLC. However, the value of PCI for NSCLC is still controversial. This paper reviews the progress of the efficacy and adverse reactions after PCI treatment for patients with NSCLC.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Cancer Research and Clinic
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS